CoronaryAtlas logo
CoronaryAtlas
c-Kit
Pathway / Myocardial injury (shared endpoint)

c-Kit

KITprotein

c-Kit+ cardiac progenitor cells mobilize in response to myocardial necrosis, contributing to post-MI remodeling and repair.

Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencelow
RationaleCardiac stem/progenitor cell marker; reflects cardiomyocyte injury and reparative response.
Druggability
DruggableYes
Known drugs / candidates38
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000157404

Type I vs Type II discrimination

ScoresType-II-associated
R — rupture / Type-I
—
C — confounder / Type-II
67
A — assay feasibility
72
E — evidence strength
21
T1DI (composite)
4
Specificity differential (R−C)-52
Confounder panel (Type-II drivers)
1sepsis / systemic inflammationn/a
2anemia / acute blood lossmag 2
3hypovolemia / dehydrationn/a
4tachyarrhythmian/a
5hypoxemia / respiratory failuremag 2
6hypertensive emergencyn/a
7high-demand / peri-operative stressn/a
Coverage: 2/7 confounders with evidence
Tier: deep-scored (abstract-extracted) · 6 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(2)

Clinical trials(1)